Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01376050 · ClinicalTrials.gov registry record · NA

Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers

A NA study, sponsored by Erchonia Corporation.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT01376050 is a NA study that was terminated before completion, run by Erchonia Corporation. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01376050, a NA study, was terminated before completion, sponsored by Erchonia Corporation.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether low level laser light therapy is effective as an adjunctive therapy to the healing of venous stasis leg ulcers.

Interventions

  • DEVICE Placebo Laser
  • DEVICE Erchonia ML Scanner (MLS)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2011-06
Est. Completion 2013-12
Phase NA

Sponsor

Erchonia Corporation

34 total trials

What the Registry Record Tells You About NCT01376050

The ClinicalTrials.gov registry entry for NCT01376050 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo Laser is the first listed.

NCT01376050 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01376050 about?

NCT01376050 is a clinical study titled "Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers". The purpose of this study is to determine whether low level laser light therapy is effective as an adjunctive therapy to the healing of venous stasis leg ulcers.

What is the current status of trial NCT01376050?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2011-06. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01376050?

The interventions under investigation include: Placebo Laser (DEVICE), Erchonia ML Scanner (MLS) (DEVICE).

Who is sponsoring clinical trial NCT01376050?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.